Obeid Mohammad A, Haifawi Saja, Khadra Ibrahim
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, G4 0RE Glasgow, United Kingdom.
Int J Pharm X. 2023 Feb 4;5:100168. doi: 10.1016/j.ijpx.2023.100168. eCollection 2023 Dec.
The aim of this work was to assess the impact of solvent selection on the characteristics of niosomes prepared by microfluidic mixing. To achieve this, niosomes were manufactured using bench-scale microfluidic mixing systems by changing the type of aqueous and/or organic solvents used to prepare the particles. Niosomes were prepared using different non-ionic surfactants and cholesterol compositions with different solvents and evaluated to investigate the influence of organic and aqueous solvents on the particle's physiochemical characteristics. Here we demonstrated that the solvent selection is a key factor to be considered during the preparation of niosomes with microfluidic mixing. The type of organic solvent was shown to significantly affect the size and the size distribution of the prepared particles. In general, niosome size increased with increasing organic solvent polarity, without affecting the niosomes stability. Moreover, changing the aqueous solvent used to hydrate the lipid components significantly ( < 0.05) affected the characteristics of the prepared niosomes in terms of particles size, size distribution, and surface charge. This impact of solvent selection on the final product is dependent on the lipid components where niosomes prepared with different compositions will have different characteristics when changing the type of organic and/or aqueous solvents. The apparent encapsulation efficiency of quinine as a model hydrophobic drug was subsequently shown to be significantly ( < 0.05) affected by the type of the organic solvent used to prepare the niosomes, while the impact of the organic solvent had less impact on the apparent encapsulation of atenolol as a model hydrophilic drug.
这项工作的目的是评估溶剂选择对通过微流混合制备的脂质体特性的影响。为实现这一目标,使用台式微流混合系统制备脂质体,改变用于制备颗粒的水性和/或有机溶剂的类型。使用不同的非离子表面活性剂和胆固醇组合物以及不同的溶剂制备脂质体,并进行评估以研究有机溶剂和水性溶剂对颗粒理化特性的影响。在此我们证明,在通过微流混合制备脂质体的过程中,溶剂选择是一个需要考虑的关键因素。结果表明,有机溶剂的类型对所制备颗粒的大小和大小分布有显著影响。一般来说,脂质体大小随有机溶剂极性的增加而增大,而不影响脂质体的稳定性。此外,改变用于水合脂质成分的水性溶剂对所制备脂质体的颗粒大小、大小分布和表面电荷特性有显著影响(<0.05)。溶剂选择对最终产品的这种影响取决于脂质成分,当改变有机溶剂和/或水性溶剂的类型时,用不同组合物制备的脂质体将具有不同的特性。随后表明,作为模型疏水药物的奎宁的表观包封效率受用于制备脂质体的有机溶剂类型的显著影响(<0.05),而有机溶剂对作为模型亲水药物的阿替洛尔的表观包封影响较小。